ONIST - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

6443-50-1

Benzeneethanimidamide,N-[2-(3-methoxyphenoxy)propyl]-3-methyl-;
Acetamidine,N-[2-(m-methoxyphenoxy)propyl]-2-m-tolyl- (7CI,8CI);
Xylamidine;
Xylamidine(5-hydroxytryptamine antagONIST)

Benzeneethanol,4-chloro-a-[2-(dimethylamino)-1-methylethyl]-a-methyl-, hydrochloride (1:1);
Benzeneethanol,4-chloro-a-[2-(dimethylamino)-1-methylethyl]-a-methyl-, hydrochloride (9CI);
Phenethyl alcohol, p-chloro-a-[2-(dimethylamino)-1-methylethyl]-a-methyl-, hydrochloride (7CI,8CI);
Biotertussin;
Clobutinol hydrochloride;
KAT 256;
Silom;
Silomat;
SilONIST

Furan,tetrahydro-2-propyl-5-(3,4,5-trimethoxyphenyl)-;
JS 1;
JS 1(antagONIST)

L-Methioninamide,L-arginyl-D-tryptophyl-N-methyl-L-phenylalanyl-D-tryptophyl-L-leucyl-;
AntagONISTG;
[Arg6,D-Trp7,9,N-MePhe8]-Substance P(6-11)

1,1-二甲基-4-苯基哌嗪翁磺化物

Piperazinium,1,1-dimethyl-4-phenyl-, iodide (1:1);
1,1-Dimethyl-4-phenylpiperaziniumiodide (6CI);
Piperazinium, 1,1-dimethyl-4-phenyl-, iodide (8CI,9CI);
1,1-Dimethyl-4-phenylpiperazineiodide;
DMPP;
DMPP (nicotinic agONIST);
DMPP iodide;
Dimethylphenylpiperaziniumiodide;
N,N-Dimethyl-N'-phenylpiperazinium iodide

WB 4101盐酸盐

1,4-Benzodioxin-2-methanamine,N-[2-(2,6-dimethoxyphenoxy)ethyl]-2,3-dihydro-;
1,4-Benzodioxan-2-methylamine,N-[2-(2,6-dimethoxyphenoxy)ethyl]- (7CI,8CI);
(?à)-WB 4101;
WB 4101;
WB 4101 (antagONIST)

1-Naphthalenesulfonamide,N-(8-aminooctyl)-5-iodo-;
J 8;
J 8(calmodulin antagONIST)

2-Piperazinecarboxylicacid, 4-(phosphonomethyl)-;
4-(PHOSPHONOMETHYL)-2-PIPERAZINECARBOXYLIC ACID;
2-(PHOSPHONOMETHYL)-PENTANEDIOIC ACID;
2-PHOSPHONOMETHYL-PENTANEDOIC ACID;
PMPA;
PMPA(NMDAantagONIST)

5-Pyrimidinemethanol,4-amino-2-methyl-;
2-Methyl-4-amino-5-(hydroxymethyl)pyrimidine;
2-Methyl-4-amino-5-pyrimidinemethanol;
2-Methyl-5-hydroxymethyl-6-aminopyrimidine;
2-Methyl-6-amino-5-hydroxymethylpyrimidine;
4-Amino-2-methyl-5-hydroxymethylpyrimidine;
4-Amino-2-methyl-5-pyrimidinemethanol;
4-Amino-5-hydroxymethyl-2-methylpyrimidine;
6-Amino-5-hydroxymethyl-2-methylpyrimidine;
NSC 28247;
OMPM;
Pyramin;
Pyramine;
Pyramine (pyridoxine antagONIST);
Pyrazan;
TXP;
Toxopyrimidine

5-Heptenoic acid,7-[(1R,2S,3S,4S)-3-[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-yl]-, (5Z)-rel-;
5-Heptenoicacid, 7-[3-[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-yl]-, [1a,2a(Z),3b,4a]-(?à)-;
(?à)-S 145;
5-Heptenoic acid,7-[3-[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-yl]-, [1a,2a(Z),3b,4a]-;
S 145;
S 145 (thromboxaneantagONIST)

(D-ARG1,D-PHE5,D-TRP7·9,LEU11)-SUBSTANCE P

D-ARG-PRO-LYS-PRO-D-PHE-GLN-D-TRP-PHE-D-TRP-LEU-LEU-NH2;
[D-ARG1, D-PHE5, D-TRP7,9, LEU11]-SUBSTANCE P;
D-ARG-PRO-LYS-PRO-D-PHE-GLN-D-TRP-PHE-D-TRP-LEU-LEU-NH2;
H-D-ARG-PRO-LYS-PRO-D-PHE-GLN-D-TRP-PHE-D-TRP-LEU-LEU-NH2;
substance P, Phe(5)-Trp(7,9)-Leu(11)-;
Substance P, [D-Arg1, D-Phe5, D-Trp7,9, Leu11];
AntagONISTD, D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2;
M.W. 1516.85 C79H109N19O12;
D-Arg-L-Pro-L-Lys-L-Pro-D-Phe-L-Gln-D-Trp-L-Phe-D-Trp-L-Leu-L-Leu-NH2

AY-NH2

H-ALA-TYR-PRO-GLY-LYS-PHE-NH2;
PROTEASE-ACTIVATED RECEPTOR-4 AGONIST AMIDE;
PAR-4 AGONIST AMIDE;
H-ALA-TYR-PRO-GLY-LYS-PHE-NH2;
AY-NH2;
AYPGKFAMIDE;
AYPGKF-NH2;
(ALA1)-COAGULATION FACTOR II RECEPTOR-LIKE 3 (1-6) AMIDE (MOUSE);
(ALA1)-PROTEINASE ACTIVATED RECEPTOR 4 (1-6) AMIDE (MOUSE)

C: DTRP-DASP-PRO-DVAL-LEU

BQ-123 SODIUM SALT;
BQ-123;
BQ-123 SODIUM SALT;
ETA-RECEPTOR ANTAGONIST;
C(DTRP-DASP-PRO-DVAL-LEU);
CYCLO (D-ALPHA-ASPARTYL-L-PROLYL-D-VALYL-L-LEUCYL-D-TRYPTOPHYL);
CYCLO(D-ASP-PRO-D-VAL-LEU-D-TRP);
CYCLO(D-ASP-PRO-D-VAL-LEU-DTRP NA);
CYCLO(-D-TRP-D-ASP-PRO-D-VAL-LEU)

紫堇碱盐酸盐

BULBOCAPNINE HYDROCHLORIDE;
BULBOCAPNINE HCL;
(+)-BULBOCAPNINE HYDROCHLORIDE;
BULBOCAPNINE HYDROCHLORIDE;
10-methoxy-1,2-(methylenedioxy)-6a-alpha-aporphin-11-ohydrochloride;
10-methoxy-1,2-(methylenedioxy)-6a-alpha-aporphin-11-olhydrochloride;
N-METHYLLAUNOBINE HYDROCHLORIDE;
(+)-BULBOCAPNINE HYDROCHLORIDE DOPAMINE ANTAGONIST;
Buibocapnine hydrochloride

CIS-4-AMINOCROTONIC ACID;
CIS-4-AMINOCROTONIC ACID (CACA) \ GABAC RECEPTOR AGONIST;
4-Amino-cis-2-butenoic acid, CACA

(±)-1-[2,3-(二氢-7-甲基氢茚-4-基)氧]-3-[(1-甲基乙基)氨基]-2-丁醇盐酸盐

ICI 204,448 HYDROCHLORIDE;
ici204448;
(RS)-[3-[1-[[(3,4-DICHLOROPHENYL)ACETYL]METHYLAMINO]-2-(1-PYRROLIDINYL)ETHYL]PHENOXY]ACETIC ACID HYDROCHLORIDE;
ICI 204,448 HYDROCHLORIDE;
ICI 204,448 HCL K-OPIOID AGONIST THAT;
(R,S)-(3-(1-(((3,4-Dichlorophenyl)acetyl)methylamino)-2-(1-pyrrolidinyl)ethyl)phenoxy)aceticacidhydrochloride;
R,S-[3-[1-[[(3,4-Dichlorophenyl)acetyl]methylamino]-2-(1-pyrrolidinyl)ethyl] phenoxy]-acetic acid hydrochloride, (±)-1-[2,3-(Dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol hydrochloride

R(-)-2,10,11-三羟基阿朴菲氢

R(-)-2 10 11-TRIHYDROXYAPORPHINE;
R(-)-2 10 11-TRIHYDROXYAPORPHINE;
R(-)-2,10,11-TRIHYDROXYAPORPHINE HYDROBR OMIDEDOPAMINE AGONIST >

GP ANTAGONIST-2A;
ARG-PRO-LYS-PRO-GLN-GLN-D-TRP-PHE-D-TRP-D-TRP-MET-NH2;
[D-TRP7,9,10]-SUBSTANCE P;
H-ARG-PRO-LYS-PRO-GLN-GLN-D-TRP-PHE-D-TRP-D-TRP-MET-NH2;
GP ANTAGONIST-2A;
RPKPQQDWFDWDWM;
Substance P, [D-Trp7,9,10];
M.W. 1588.89 C79H105N21O13S

VIP ANTAGONIST

H-LYS-PRO-ARG-ARG-PRO-TYR-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SE;
H-LYS-PRO-ARG-ARG-PRO-TYR-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2;
KPRRPYTDNYTRLRKQMAVKKYLNSILN-NH2;
VASOACTIVE INTESTINAL PEPTIDE ANTAGONIST;
VIP ANTAGONIST;
(lys1,pro2,5,arg3,4,tyr6)-vasoactive*intestinal P;
(LYS1 PRO2 5 ARG3 4 TYR6)-VASOACTIVE &;
(VIP-neurotensin) hybrid antagONIST;
H-Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2

2-FUROYL-LEU-ILE-GLY-ARG-LEU-ORN-NH2

2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2;
PAR-2 AGONIST II;
PROTEINASE ACTIVATED RECEPTOR-2 AGONIST II;
2-(2-FUROYL)-LEU-ILE-GLY-ARG-LEU-ORN-NH2;
2-(2-FUROYL)-LIGRLOAMIDE;
2-(2-FUROYL)-PAR-2 (2-6)-ORN AMIDE (MOUSE, RAT);
2F-LIGRLO-AMIDE;
2-FUROYL-LEU-ILE-GLY-ARG-LEU-ORN-NH2;
2-FUROYL-LIGRLO-AMIDE

C36H63N11O8

详情

供应商

化工产品